(Press-News.org) BOSTON -- Two oral targeted drugs approved for metastatic kidney cancer worked equally well, but one proved superior in tolerability, according to results of a large international clinical trial led by researchers at Dana-Farber Cancer Institute.
Pazopanib (Votrient) and sunitinib (Sutent), both recently approved as first-line treatments for advanced renal cell cancer, had similar benefits in delaying progression of the disease, but the safety profile and many measures of quality of life favored pazopanib, suggesting a potential shift in standard of care in metastatic kidney cancer.
The study's findings are reported in the August 22 issue of the New England Journal of Medicine.
"Tolerability is a big part of the equation when drugs work equally well," said Toni Choueiri, MD, director of the Kidney Cancer Center at Dana-Farber/Brigham and Women's Cancer Care (DF/BWCC). "If patients are going to live the same life span, why not use the one that's better tolerated?"
Choueiri, who is also an associate professor of medicine at Harvard Medical School, is senior author of the report of a phase 3 trial of 1,100 metastatic kidney cancer patients treated at multiple centers in 14 countries. Robert Motzer, MD, of Memorial Sloan-Kettering Cancer Center, is the first author.
The trial, sponsored by GlaxoSmithKline Pharmaceuticals, which manufactures pazopanib, compared the efficacy, safety and tolerability of pazopanib and sunitinib, two similar tyrosine kinase inhibitors that hinder cancer cell growth by disrupting several biological pathways. Both drugs target multiple cell-surface tyrosine kinase receptors, including receptors for vascular endothelial growth factor (VEGF), a protein that cancer cells co-opt to form new blood vessels to support tumor growth.
The Food and Drug Administration approved sunitinib in 2006 and pazopanib in 2009 to treat advanced kidney cancer, which is notoriously resistant to conventional chemotherapy. The drugs previously demonstrated improved progression-free survival compared to Interferon or placebo; the current trial tested them head-to-head.
The median time before the cancer progressed was comparable: 8.4 months for pazopanib and 9.5 months for sunitinib. Median overall survival was also similar – 28.4 months for patients taking pazopanib and 29.3 months for sunitinib.
Pazopanib patients had a higher rate of liver enzyme abnormalities, in some cases leading to discontinuation of the drug. However, pazopanib patients had lower rates of blood cell abnormalities, hand and foot soreness, mouth sores, low thyroid activity, nausea, and fatigue.
Most important, pazopanib was rated superior to sunitinib on 11 or 14 measures of quality of life. In addition, pazopanib patients had fewer phone consultations with providers and visited emergency rooms less frequently – a difference the researchers said is significant because it could influence cost-benefit comparisons.
INFORMATION:
The study was funded by GlaxoSmithKline Pharmaceuticals.
The paper's other authors are affiliated with Baylor Sammons Cancer Center/Texas Oncology, Dallas; Robert H. Lurie Comprehensive Cancer Center, Chicago; Florida Cancer Specialists, Fort Myers, Fla.; University of Manchester and The Christie Hospital, NHS Foundation Trust, Manchester, UK; Peking University Cancer Hospital, Beijing; Mount Vernon Hospital, Middlesex, UK; University of Munich; University of Western Sydney School of Medicine, Australia; Sylvester Cancer Center, Miami; The Royal Free Hospital Clinical Oncology, London; Addenbrooke's Hospital, Cambridge, UK; Peking University First Hospital, Beijing; Institute of Cancer Sciences University of Glasgow; Kinki University Faculty of Medicine, Osaka, Japan; IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy; Karolinska Institutet, Karolinska University Hospital, Stockholm; Cancer Hospital, CAMS & PUMC, Beijing; San Camillo and Forlanini Hospitals, Rome; and GlaxoSmithKline, Inc.
--Written by Richard Saltus, Dana-Farber Cancer Institute
Pazopanib shows better quality-of-life in advanced kidney cancer
2013-08-22
ELSE PRESS RELEASES FROM THIS DATE:
Study finds mother's genes can impact aging process
2013-08-22
As we age, our cells change and become damaged. Now, researchers at Karolinska Institutet and the Max Planck Institute for Biology of Aging have shown that aging is determined not only by the accumulation of changes during our lifetime but also by the genes we acquire from our mothers. The results of the study are published in the journal Nature.
There are many causes of aging that are determined by an accumulation of various kinds of changes that impair the function of bodily organs. Of particular importance in aging, however, seems to be the changes that occur in the ...
A brighter method for measuring the surface gravity of distant stars
2013-08-22
Astronomers have found a clever new way to slice and dice the flickering light from a distant star in a way that reveals the strength of gravity at its surface.
That is important because a star's surface gravity is one of the key properties that astronomers use to calculate a star's physical properties and assess its evolutionary state.
The new technique can also be used to significantly improve estimates of the sizes of the hundreds of exoplanets that have been discovered in the last 20 years. Current estimates have uncertainties ranging from 50 percent to 200 percent. ...
New results from Daya Bay
2013-08-22
The international Daya Bay Collaboration has announced new results about the transformations of neutrinos - elusive, ghostlike particles that carry invaluable clues about the makeup of the early universe. The latest findings include the collaboration's first data on how neutrino oscillation – in which neutrinos mix and change into other "flavors," or types, as they travel – varies with neutrino energy, allowing the measurement of a key difference in neutrino masses known as "mass splitting."
"Understanding the subtle details of neutrino oscillations and other properties ...
Berlin researchers open a door for solid state physics
2013-08-22
Without the currently available plethora of X-ray methods, basic research in the physical sciences would be unthinkable. The methods are used in solid state physics, in the analysis of biological structures, and even art historians have X-rays to thank for many new insights. Now, scientists at the Helmholtz Center Berlin (HZB) have identified yet another area of application. The team around Dr. Martin Beye and Prof. Alexander Föhlisch was able to show that solids lend themselves to X-ray analysis based on nonlinear physical effects. Until now, this could only be done using ...
Warming Antarctic seas likely to impact on krill habitats
2013-08-22
Antarctic krill are usually less than 6 cm in length but their size belies the major role they play in sustaining much of the life in the Southern Ocean. They are the primary food source for many species of whales, seals, penguins and fish.
Krill are known to be sensitive to sea temperature, especially in the areas where they grow as adults. This has prompted scientists to try to understand how they might respond to the effects of further climate change.
Using statistical models, a team of researchers from the British Antarctic Survey and Plymouth Marine Laboratory assessed ...
Researchers reveal hunter-gatherers' taste for spice
2013-08-22
Our early ancestors had a taste for spicy food, new research led by the University of York has revealed.
Archaeologists at York, working with colleagues in Denmark, Germany and Spain, have found evidence of the use of spices in cuisine at the transition to agriculture. The researchers discovered traces of garlic mustard on the charred remains of pottery dating back nearly 7,000 years.
The silicate remains of garlic mustard (Alliaria petiolata) along with animal and fish residues were discovered through microfossil analysis of carbonised food deposits from pots found at ...
Researchers agree that Alzheimer's test results could be released to research participants
2013-08-22
PHILADELPHIA - A leading group of Alzheimer's researchers contends that, as biomarkers to detect signals of the disease improve at providing clinically meaningful information, researchers will need guidance on how to constructively disclose test results and track how disclosure impacts both patients and the data collected in research studies. A survey conducted by a group including experts from the Perelman School of Medicine at the University of Pennsylvania found that a majority of Alzheimer's researchers supported disclosure of results to study participants. The study ...
Shorter working hours do not guarantee happier workers
2013-08-22
A reduction in working hours does not necessarily mean happier employees, as it might merely be adding stress to their general working environment. This is according to a study by Robert Rudolf of Korea University, Seoul, that looks at the impact of South Korea's recently introduced Five-Day Working Policy. The paper, published online in Springer's Journal of Happiness Studies, focuses on the overall individual and family happiness of married and co-residing couples living with children, and also assesses the impact of working hours on people's overall job and life satisfaction. ...
Antipsychotic drug use in children for mood/behavior disorders increases type 2 diabetes risk
2013-08-22
Prescribing of "atypical" antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows.
Young people using medications like risperidone, quetiapine, aripiprazol and olanzapine led to a threefold increased risk of developing type 2 diabetes within the first year of taking the drug, according to the study published Aug. 21 in the journal JAMA Psychiatry.
While other studies have shown an increased risk for type 2 diabetes associated ...
Putting sleep disorders to bed
2013-08-22
This news release is available in French. Overnight flights across the Atlantic, graveyard shifts, stress-induced insomnia are all prime culprits in keeping us from getting a good night's sleep. Thanks to new research from McGill University and Concordia University, however, these common sleep disturbances may one day be put to bed.
The rotation of the earth generates day and night. It also confers daily rhythms to all living beings. In mammals, something known as a "circadian clock" in the brain drives daily rhythms in sleep and wakefulness, feeding and metabolism, ...